Randomized trial compares overall survival rates in PIK3CA-mutated colon cancer patients receiving aspirin versus placebo, indicating its potential benefit.
Overall survival. Kaplan-Meier curve of overall survival (including unstratified hazard ratio) – comparison between patients randomized to aspirin (in red) versus placebo (in blue).
No takes yet. Share an insight, caveat, or question.
Güller et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: